Farkouh of New York University, the lead author of an analysis of the Prexige heart data, insists that the data in the trial are strong enough to makeaconclusion than any heart problems with the drug are not something to worry about.
But to say we are behind because we do not spend as many federal dollars as other domestic industries or other nations may be too simple aconclusion to make.